维普中文期刊产品整合服务

Zinc-substituted hemoglobin with specific drug binding sites and fatty acid resistance ability for enhanced photodynamic therapy

查看全文 作　　者：Yiting [1]Xu;Jiamei [1]Xu;Xiaoxiao [1]Hu;Xin [1]Xia;Qian [1]Dong;Zhangkun [1]Liu;Zhuo [1]Chen;Weihong [1,2]Tan 高影响力作者 机构地区：[1]Molecular Science and Biomedicine Laboratory,State Key Laboratory of Chemo/Biosensing and Chemometrics,College of Chemistry and Chemical Engineering,College of Life Sciences,Aptamer Engineering Center of Hunan Province,Hunan Provincial Key Laboratory of Biomacromolecular Chemical Biology,Hunan University,Changsha 410082,China;[2]Department of Chemistry,Departments of Physiology and Functional Genomics,Center for Research at the Bio/Nano Interface,UF Health Cancer Center,UF Genetics Institute and McKnight Brain Institute,University of Florida,Gainesville,Florida 32611,USA高影响力机构 出　　处：《Nano Research》索引2019年第12卷第8期,共8页高影响力期刊 基　　金：supported by the National Natural Science Foundation of China (Nos.21522501, 21521063, 31701249, and 31601125);Hunan Provincial Natural Science Foundation of China (Nos.2018JJ1007 and 2018JJ3037);the keypoint research and invention program of Hunan province (No.2017DK2011);the Science and Technology Development Fund of Macao S.A.R (FDCT, 196/2017/A3). 摘　　要：Precisely designed protein-based nanodrugs, as a kind of colloidal drug system, have attracted significant attention in tumor therapy because of their refined drug loading ratio, controlled delivery efficacy and natural biocompatibility. However, most drugs are conjugated to the protein carriers randomly without specific binding sites. Moreover, such sites could easily be replaced by lipophilic molecules in the physiological environment and result in low delivery efficiency. With strong and specific binding locations especially comparatively narrow spatial binding sites and nonflexible structure, hemin (FePPIX)-free hemoglobin or apohemoglobin (apoHb), as a natural metalloporphyrin protein carrier, represents great potential in bioapplication. Therefore, we herein introduce a folate acid (FA) modified, zinc-substituted hemoglobin (ZnPHb-FA) as a naturally occurring protein matrix-based photosensitizer for cancer photodynamic therapy (PDT). Noncovalent inserted ZnPPIX molecules in apoHb possess an extremely stable property and significant recovered photoproperties with superior biocompatibility and phototoxicity, both in vitro and in vivo. This stability was verified by molecular docking analysis and calculation of binding constant, representing a total of five drug binding sites of apoHb for ZnPPIX molecules, four of which are energetically favorable (△G value of -11.9 kcal/mol), and one which is energetically acceptable (△G value of -9 kcal/mol). Folate acid modification has been shown to efficiently enhance the internalization and retention time of ZnPHb nanodrug. ZnPHb-FA is also an efficient depressor of hemin oxygenase-1 (HO-1), which could, in turn, lower the antioxidant ability of cancer cells by decreasing the production of biiirublin. Results in vitro and in vivo both indicated that the firmly combination of apoHb and ZnPPIX described here represents a novel and efficient protein nanodrug systems for cancer therapy. 关 键 词：natural METALLOPORPHYRIN protein carrier SPECIFIC drug binding SITES fatty acid RESISTANCE ABILITY photodynamic therapy hemin oxygenase-1 (HO-1)
相关文献

参考文献(62)

引证文献(2)

耦合文献(2)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费